z-logo
Premium
Airway hyperreactivity is frequent in non‐asthmatic children with sickle cell disease
Author(s) -
Shilo Natalie R.,
Alawadi Aceel,
AllardCoutu Alexandra,
Robitaille Nancy,
Pastore Yves,
Bérubé Denis,
Jacob Sheila V.,
Abish Sharon,
Dauletbaev Nurlan,
Lands Larry C.
Publication year - 2016
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.23374
Subject(s) - medicine , asthma , concomitant , allergy , exhaled breath condensate , acute chest syndrome , methacholine , respiratory disease , immunology , leukotriene , disease , gastroenterology , sickle cell anemia , lung
Summary Background Asthma is associated with poorer outcomes in sickle cell disease (SCD). Whether AHR can exist in SCD as a distinct entity, separate and independent of asthma, is unknown. Aims Our goal was to elucidate the prevalence of AHR, as measured by a methacholine challenge test (MCT), in children with SCD who did not have concomitant asthma or any recent history of acute chest syndrome (ACS). To determine if AHR was associated with asthma‐like symptoms, we compared the results of the MCT to a validated asthma questionnaire. We also examined if a correlation between AHR and inflammatory markers exists. Methods AHR was identified with a positive MCT defined as a provocation concentration (PC 20 ) < 4 mg/ml. The children and/or their parents completed the ISAAC (International Study of Asthma and Allergies in Children) questionnaire. We obtained blood, urine, and exhaled breath condensate samples. We measured cysteinyl leukotriene levels in urine and exhaled breath condensate via enzyme immunoassay. Results Twenty‐nine of forty children (72.5%) had a positive MCT. Nine (31.0%) also reported asthma‐like symptoms on questionnaire. Inflammatory markers did not correlate with AHR. Among MCT positive subjects, those on hydroxyurea had significantly less severe AHR as quantified by PC 20 ( P  = 0.014). Conclusions In children with SCD, there is a high prevalence of AHR that is not associated with asthma‐like symptoms. AHR may be a distinct entity in children with SCD, existing in the absence of concomitant asthma. Hydroxyurea therapy might lessen the severity of AHR in affected individuals. Pediatr Pulmonol. 2016; 51:950–957 . © 2015 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here